Babu Philip
About Babu Philip
Data last updated:
Babu Philip is a Whole-Time Director at Incus Pharmaceuticals Private Limited (since 2009) and Director at Tertiary Care Private Limited (since 2020). The companies operate in Pharma and Internet. The 2 current companies with reported revenue have a combined latest revenue of ₹6.39 Cr; the largest is Incus Pharmaceuticals Private Limited at ₹6.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Incus Pharmaceuticals Private Limited U51397KL2009PTC024907 | Whole-Time Director | 21 Oct 2009 | 2009 | ₹6.38 Cr (FY 2025) | Active |
 Tertiary Care Private Limited U85100KL2020PTC063568 | Director | 12 Aug 2020 | 2020 | ₹88,731 (FY 2024) | Active |
Board colleagues of Babu Philip
| Name | DIN | Company | Designation |
|---|---|---|---|
| Narayanan Priyaranjan Das | 02798203 | Incus Pharmaceuticals Private Limited | Managing Director |
| Plammoottil Janardhanan Pillai Abhilash | 02798195 | Incus Pharmaceuticals Private Limited | Whole-Time Director |
| Thulaseedharan Pillai Suresh Kumar | 02798228 | Incus Pharmaceuticals Private Limited | Whole-Time Director |
| Peringelil Gopalakrishna Pillai Gopakumar | 08830955 | Tertiary Care Private Limited | Director |
| Ramachandran Madhav Chandran | 01863202 | Tertiary Care Private Limited | Director |
| Saji Chandran Kalathil | 08643011 | Tertiary Care Private Limited | Managing Director |
| Sharin Peethamber | 09256954 | Tertiary Care Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Babu Philip
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babu Philip
Babu Philip currently holds 2 directorships: Incus Pharmaceuticals Private Limited (Whole-Time Director, since 21 Oct 2009, revenue ₹6.38 Cr (FY 2025)); Tertiary Care Private Limited (Director, since 12 Aug 2020, revenue ₹88,731 (FY 2024)).
Babu Philip was first appointed on 21 Oct 2009 as Whole-Time Director at Incus Pharmaceuticals Private Limited. The most recent appointment on record is 12 Aug 2020 at Tertiary Care Private Limited.
The 2 current companies of Babu Philip that report revenue have a combined latest revenue of ₹6.39 Cr: Incus Pharmaceuticals Private Limited ₹6.38 Cr (FY 2025); Tertiary Care Private Limited ₹88,731 (FY 2024).
The current boards of Babu Philip's companies include Narayanan Priyaranjan Das (Incus Pharmaceuticals Private Limited), Plammoottil Janardhanan Pillai Abhilash (Incus Pharmaceuticals Private Limited), Thulaseedharan Pillai Suresh Kumar (Incus Pharmaceuticals Private Limited), Peringelil Gopalakrishna Pillai Gopakumar (Tertiary Care Private Limited), Ramachandran Madhav Chandran (Tertiary Care Private Limited), Saji Chandran Kalathil (Tertiary Care Private Limited), among others.